SCHEMBL187459

SCHEMBL187459

COC(=O)C=C(NC(C)=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.46
TSHR P16473 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
NPC1 O15118 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
EPHX1 P07099 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
GLA P06280 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5142053 1.00 SRC (0.46) SRCTSHRSMN1; SMN2MTNR1AMTNR1B
SCHEMBL14247549 1.00 SRC (0.46) SRCTSHRSMN1; SMN2MTNR1AMTNR1B
SCHEMBL6648182 0.85 MTNR1A (0.44) SRCTSHRSMN1; SMN2MTNR1AMTNR1B
SCHEMBL5072835 0.85 MTNR1A (0.44) SRCTSHRSMN1; SMN2MTNR1AMTNR1B
SCHEMBL388144 0.85 MTNR1A (0.44) SRCTSHRSMN1; SMN2MTNR1AMTNR1B
SCHEMBL14588759 0.85 TDP1 (0.47) TSHRSMN1; SMN2NPC1MAPTRAB9A
SCHEMBL11720759 0.85 CA1 (0.47) TSHRSMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL636993 0.84 MAPT (0.46) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL13662396 0.84 MAPT (0.46) SMN1; SMN2NPC1MAPTRAB9AALDH1A1
SCHEMBL387761 0.84 MTNR1A (0.43) SRCTSHRSMN1; SMN2MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036790-A Chiral phosphine-acyclic phosphoramidite ligand, preparation method and application thereof 中国科学院大连化学物理研究所 2026-05-15 CN disclosed
CN-113121615-B Ferrocene boracic chiral diphosphine ligand and preparation method and application thereof 南方科技大学 2023-02-17 CN disclosed
CN-112824422-B Chiral ferrocene-indole diphosphine ligand as well as preparation method and application thereof 中国科学院大连化学物理研究所(CN) 2023-01-13 CN disclosed
CN-113121615-A Ferrocene boracic chiral diphosphine ligand and preparation method and application thereof 南方科技大学 2021-07-16 CN disclosed
CN-112824423-A Chiral ferrocenylphosphine-indolylaminophosphine ligand and preparation method and application thereof 中国科学院大连化学物理研究所 2021-05-21 CN disclosed
EP-3768688-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS Université de Bourgogne (FR) 2021-01-27 EP disclosed
US-20200407381-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS Université de Bourgogne (FR) 2020-12-31 US disclosed
CN-111868065-A C-sterically hindered P-chirally derived organophosphorus compounds 勃艮第大学 2020-10-30 CN disclosed
WO-2019180084-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS Université de Bourgogne (FR) 2019-09-26 WO disclosed
CN-108339571-A P- chiral source organic phosphorus compounds 国家科学研究中心 2018-07-31 CN disclosed
US-20020042540-A1 New 6,6'-bis-(1-phosphanorbornadiene) diphosphines, their preparation and their uses MATHEY FRANCOIS (FR) 2002-04-11 US disclosed
WO-2002002578-A1 FERROCENYL DIPHOSPHINES AND THEIR USE SOLVIAS AG (CH) 2002-01-10 WO disclosed
US-6288279-B1 THEIR PREPARATION PROCESS AND THEIR USE IN ASYMMETRICAL CATALYSIS. REARRANGING A DIPHOSPHOLE, REACTING THE DIPHOSPHOLE WITH AN ACETYLENIC COMPOUND TO FORM THE DIPHOSPHINE RHODIA CHIMIE (FR) 2001-09-11 US disclosed
US-6037493-A Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof RHONE-POULENC CHIMIE (FR) 2000-03-14 US disclosed
WO-1999059721-A1 CATALYTIC ASYMMETRIC HYDROGENATION, HYDROFORMYLATION, AND HYDROVINYLATION VIA TRANSITION METAL CATALYSTS WITH PHOSPHINES AND PHOSPHITES THE PENN STATE RESEARCH FOUNDATION (US) 1999-11-25 WO disclosed
US-5783738-A Optically active diphosphines, preparation thereof according to a process for the resolution of the racemic mixture and use thereof RHONE-POULENC CHIMIE (FR) 1998-07-21 US disclosed
EP-0198397-B1 METHOD OF PRODUCING L-PHENYLALANINE KURARAY CO., LTD. (JP) 1993-01-07 EP disclosed
US-4743547-A PURITY, ENZYME HYDROLYSIS KURARAY CO., LTD. (JP) 1988-05-10 US disclosed
US-4654176-A Sulphonated chiral phosphines, their preparation and their use RHONE-POULENC SANTE (FR) 1987-03-31 US disclosed
EP-0198397-A2 Method of producing L-phenylalanine KURARAY CO., LTD. (JP) 1986-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407381-A1 C-BULKY P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS PLCG1, PLCG2, ACHE SRC 1837/4885TSHR 3498/4885SMN1; SMN2 2652/4885
US-20020042540-A1 New 6,6'-bis-(1-phosphanorbornadiene) diphosphines, their preparation and their uses PHOSPHO1, DUS2, DCPS SRC 3914/4885TSHR 4146/4885SMN1; SMN2 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.